IFI-M · BK Tissue-Specific Series

Specimen SS-F-M2-08311 // MULTI-AXIS · IFI-M

BK Tissue-Specific Series III-PR-A

Brassica oleracea

Broccoli

Tier IIIBK Tissue-Specific Series

Target Trait

1.95×

fold-change

Bitter-Attenuation+Kokumi tissue-specific dual expression

Technical Specifications

SKU

SS-F-M2-08311

Genomic Edits

7

GC Content

46.2%

Construct Length

4,040 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TAS2R38 (suppression) + CaSR

IFI Score

195

Pathway Edits

  • TAS2R38 (suppression) pathway primary gene cluster overexpression for bitter-attenuation axis activation
  • CaSR pathway primary gene cluster overexpression for kokumi axis activation
  • Bidirectional promoter system for synchronized B+K dual-axis co-expression
  • Metabolic flux partitioning between IFI-B and IFI-K pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Bitter-Attenuation-Kokumi combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for B+K simultaneous accumulation
  • Tissue-specific expression cassette deployment for optimized BK spatial patterning

Key Interventions

Dual-receptor co-activation via synchronized TAS2R38 (suppression) and CaSR pathway engineeringMetabolic flux partitioning strategy enabling simultaneous bitter-attenuation and kokumi accumulation without competing pathway suppressionTissue-specific dual expression for BK multi-axis integrationPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier III BK dual-axis tissue-specific platform for food ingredient applications requiring verified combined bitter-attenuation+kokumi sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$1499 · Tier III License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities